Retraction: Effectiveness And Safety Of Toripalimab, Camrelizumab And Sintilimab In A Real-World Cohort Of Hepatitis B Virus Associated Hepatocellular Carcinoma Patients (Retraction Of 10.1111/Bcp.14452, 2020)

The above article from British Journal of Clinical Pharmacology, published online on July 5, 2020 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn by agreement among the authors and John Wiley & Sons Ltd on behalf of the British Pharmacology Society. The withdrawal has been agreed in accordance with the authors' decision to revise their study providing the latest data.